|
Random vs. fixed effects meta-analysis
|
|
22
|
1974
|
January 20, 2024
|
|
Use of percentage change in clinical trials
|
|
16
|
628
|
April 8, 2024
|
|
Analogy between clinical trials and diagnostic tests: using likelihood ratios to interpret negative trials
|
|
12
|
1975
|
June 23, 2023
|
|
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic
|
|
34
|
2870
|
February 16, 2024
|
|
Rigor and Reproducibility in a Research Network
|
|
15
|
1576
|
December 29, 2023
|
|
Biomarker evaluation - c-statistic (AUC) and alternatives
|
|
24
|
1798
|
April 18, 2024
|
|
Providing evidence for or against accepted reference limits for a laboratory test
|
|
9
|
366
|
December 10, 2023
|
|
Fixed or random time effect?
|
|
12
|
3622
|
July 30, 2023
|
|
Risk based treatment and the validity of scales of effect
|
|
17
|
1755
|
May 22, 2023
|
|
Specifying random effects structure to achieve proper degrees of freedom
|
|
9
|
493
|
January 25, 2024
|
|
Some thoughts on uniform prior probabilities when estimating P values and confidence intervals
|
|
15
|
474
|
February 11, 2024
|
|
Data collected outside of guidelines/window
|
|
10
|
1090
|
June 13, 2023
|
|
RMS Cox PH Model
|
|
39
|
1987
|
January 22, 2024
|
|
Are there situations in which a frequentist approach is inherently better than Bayesian?
|
|
9
|
1048
|
November 16, 2023
|
|
Bayesian paired samples t-tests: Interpretation of the support of the H0
|
|
13
|
1070
|
October 16, 2023
|
|
Assessing correlation/surrogacy between 2 estimated treatment effects
|
|
9
|
451
|
February 17, 2024
|
|
Regression to the mean and parallel RCTs
|
|
13
|
1340
|
September 3, 2023
|
|
Calculating fraction of new information in Cox proportional hazard models
|
|
17
|
1235
|
December 14, 2023
|
|
Individual evaluation
|
|
24
|
1236
|
October 10, 2023
|
|
BBR: Challenges of Analyzing High Dimensional Data
|
|
12
|
544
|
November 28, 2023
|
|
Mixed models modelling
|
|
14
|
1163
|
October 26, 2023
|
|
Hybrid AI & Delphi Based Derivation of RCT and Bedside Measurements
|
|
10
|
490
|
April 10, 2024
|
|
Using a proportional odds model instead of logistic model to improve power
|
|
13
|
791
|
November 30, 2023
|
|
Substituting treatment arm with drug exposure (continuous variable) in RCT
|
|
10
|
477
|
January 8, 2024
|
|
Decision curve for decision tree model
|
|
9
|
893
|
July 3, 2023
|
|
External validation or a bigger modelling sample?
|
|
9
|
1048
|
August 12, 2023
|
|
How should an early warning system be validated?
|
|
13
|
304
|
April 17, 2024
|
|
An overview of some classification performance measures
|
|
10
|
658
|
November 26, 2023
|
|
Overlap weights for small sample RCTs
|
|
18
|
435
|
April 11, 2024
|
|
Data reduction strategy in Cox PH model and validate() interpretation
|
|
13
|
362
|
April 22, 2024
|
|
Redundancy analysis of covariates in a Cox model using flexible parametric additive models
|
|
9
|
524
|
March 22, 2024
|
|
Model Performance with Repeat Predictions
|
|
10
|
276
|
March 12, 2024
|
|
Penalized Likelihood vs. Variance Decomposition Approaches
|
|
2
|
1911
|
April 17, 2024
|
|
Counfounding and effect modification “in expectation” versus “in measure”
|
|
3
|
643
|
August 2, 2023
|
|
Immortal-time-bias vs. selection bias
|
|
2
|
188
|
April 7, 2024
|
|
Design ideas for non-inferiority trials were event rates are low
|
|
8
|
2162
|
May 21, 2023
|
|
"Spline approximation error"
|
|
4
|
681
|
June 19, 2023
|
|
Survival analysis vs. nested case-control analysis
|
|
3
|
914
|
August 14, 2023
|
|
When is it clinically reasonable to assume transportability of RCT effects?
|
|
7
|
240
|
April 7, 2024
|
|
Relationship between statistical models and machine learning algorithms
|
|
4
|
1097
|
September 17, 2023
|
|
Outlier detection
|
|
3
|
1032
|
May 11, 2023
|
|
"Amazing findings in medicine are sometimes based on one patient" — Paul Hwang
|
|
0
|
400
|
September 18, 2023
|
|
Textbook / curriculum recommendations for introductory and early statistics courses
|
|
6
|
1173
|
May 20, 2023
|
|
individual risk
|
|
6
|
975
|
May 29, 2023
|
|
Guidance of analysis of longitudinal patient reported outcomes w.r.t Joint models
|
|
4
|
696
|
August 29, 2023
|
|
Observational data with diagnosis partially determining treatment (imperfect instrumental variable?)
|
|
0
|
378
|
August 8, 2023
|
|
Treatment effect on survival in observational data with treatment times after diagnosis
|
|
4
|
646
|
May 16, 2023
|
|
Want to know how to simulate a logistic model with a certain prevalence and AUC-ROC?
|
|
2
|
464
|
October 24, 2023
|
|
Interim Analysis Plan for Observational Studies
|
|
3
|
1064
|
August 16, 2023
|
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
349
|
February 23, 2024
|